Skip to Main Content

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (D1AMOND)

Conditions

Children's Health | Mental Health & Behavioral Research

Phase II

What is the purpose of this trial?

This study is an international, multicenter, open-label, long term extension study evaluating the safety of ecopipam tablets for the treatment of children and adolescent subjects with Tourette Syndrome.

  • Trial with
    Emalex Biosciences, Inc.
  • Start Date
    08/04/2021
  • End Date
    10/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    04/05/2022
  • Study HIC
    #2000027699